BPC 157 Cost: What You Need to Know Regulatory Alert: The Legal Status of BPC 157 in Compounding and Clinical Practice Holt Law RFK Jr. promotes peptides. Now the FDA weighs easing limits on the unproven chemicals Gray Market Peptides: So Much Hype, So Little Data FDA mulls compounding for peptides previously flagged over safety risks BioSpace The Food and Drug Administration will hold a meeting this summer to consider easing restrictions on more than a half dozen peptide injections, a group of unapproved therapies that have become popular